BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 20506278)

  • 1. Nicotinamide phosphoribosyltransferase/sirtuin 1 pathway is involved in human immunodeficiency virus type 1 Tat-mediated long terminal repeat transactivation.
    Zhang HS; Sang WW; Wang YO; Liu W
    J Cell Biochem; 2010 Aug; 110(6):1464-70. PubMed ID: 20506278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tanshinone II A inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK/Nampt pathway.
    Zhang HS; Chen XY; Wu TC; Zhang FJ
    J Cell Physiol; 2014 Sep; 229(9):1193-201. PubMed ID: 24414799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol inhibited Tat-induced HIV-1 LTR transactivation via NAD(+)-dependent SIRT1 activity.
    Zhang HS; Zhou Y; Wu MR; Zhou HS; Xu F
    Life Sci; 2009 Sep; 85(13-14):484-9. PubMed ID: 19664641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of NAMPT expression by miR-182 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
    Chen XY; Zhang HS; Wu TC; Sang WW; Ruan Z
    Int J Biochem Cell Biol; 2013 Feb; 45(2):292-8. PubMed ID: 23153509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase.
    Zhang HS; Wu MR
    Virus Res; 2009 Dec; 146(1-2):51-7. PubMed ID: 19720090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation.
    Zhang HS; Ruan Z; Sang WW
    J Cell Physiol; 2011 Dec; 226(12):3385-91. PubMed ID: 21344388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-34a is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation through the SIRT1/NFκB pathway.
    Zhang HS; Chen XY; Wu TC; Sang WW; Ruan Z
    FEBS Lett; 2012 Nov; 586(23):4203-7. PubMed ID: 23103739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-217 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation by down-regulation of SIRT1.
    Zhang HS; Wu TC; Sang WW; Ruan Z
    Biochim Biophys Acta; 2012 May; 1823(5):1017-23. PubMed ID: 22406815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Akt/Nox2/NF-κB signaling pathway is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
    Zhang HS; Sang WW; Ruan Z; Wang YO
    Arch Biochem Biophys; 2011 Jan; 505(2):266-72. PubMed ID: 21029719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGCG inhibits Tat-induced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway.
    Zhang HS; Wu TC; Sang WW; Ruan Z
    Life Sci; 2012 May; 90(19-20):747-54. PubMed ID: 22480519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal regulation by hypoxia-inducible factor-2α and the NAMPT-NAD(+)-SIRT axis in articular chondrocytes is involved in osteoarthritis.
    Oh H; Kwak JS; Yang S; Gong MK; Kim JH; Rhee J; Kim SK; Kim HE; Ryu JH; Chun JS
    Osteoarthritis Cartilage; 2015 Dec; 23(12):2288-2296. PubMed ID: 26209889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of SIRT1 by HIV-1 viral protein Tat results in activation of p53 pathway.
    Thakur BK; Chandra A; Dittrich T; Welte K; Chandra P
    Biochem Biophys Res Commun; 2012 Jul; 424(2):245-50. PubMed ID: 22732402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
    Wang LF; Wang XN; Huang CC; Hu L; Xiao YF; Guan XH; Qian YS; Deng KY; Xin HB
    Lipids Health Dis; 2017 Apr; 16(1):82. PubMed ID: 28449683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT1 regulates HIV transcription via Tat deacetylation.
    Pagans S; Pedal A; North BJ; Kaehlcke K; Marshall BL; Dorr A; Hetzer-Egger C; Henklein P; Frye R; McBurney MW; Hruby H; Jung M; Verdin E; Ott M
    PLoS Biol; 2005 Feb; 3(2):e41. PubMed ID: 15719057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol differentially regulates NAMPT and SIRT1 in Hepatocarcinoma cells and primary human hepatocytes.
    Schuster S; Penke M; Gorski T; Petzold-Quinque S; Damm G; Gebhardt R; Kiess W; Garten A
    PLoS One; 2014; 9(3):e91045. PubMed ID: 24603648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide phosphoribosyltransferase postpones rat bone marrow mesenchymal stem cell senescence by mediating NAD
    Pi C; Yang Y; Sun Y; Wang H; Sun H; Ma M; Lin L; Shi Y; Li Y; Li Y; He X
    Aging (Albany NY); 2019 Jun; 11(11):3505-3522. PubMed ID: 31175267
    [No Abstract]   [Full Text] [Related]  

  • 17. Restoring NAD
    Katayoshi T; Nakajo T; Tsuji-Naito K
    J Photochem Photobiol B; 2021 Aug; 221():112238. PubMed ID: 34130091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NAMPT/E2F2/SIRT1 axis promotes proliferation and inhibits p53-dependent apoptosis in human melanoma cells.
    Zhao H; Tang W; Chen X; Wang S; Wang X; Xu H; Li L
    Biochem Biophys Res Commun; 2017 Nov; 493(1):77-84. PubMed ID: 28919418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight Loss Is Associated With Increased NAD(+)/SIRT1 Expression But Reduced PARP Activity in White Adipose Tissue.
    Rappou E; Jukarainen S; Rinnankoski-Tuikka R; Kaye S; Heinonen S; Hakkarainen A; Lundbom J; Lundbom N; Saunavaara V; Rissanen A; Virtanen KA; Pirinen E; Pietiläinen KH
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1263-73. PubMed ID: 26760174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway.
    Wang P; Xu TY; Guan YF; Tian WW; Viollet B; Rui YC; Zhai QW; Su DF; Miao CY
    Ann Neurol; 2011 Feb; 69(2):360-74. PubMed ID: 21246601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.